The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients

References

• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Knebel B, Janssen O, Hahn S, et al. Increased low grade inflammatory serum markers in patients with polycystic ovary syndrome (PCOS) and their relationship to PPARgamma gene variants. Exp Clin Endocrinol Diabetes. 2008;116(8):481–486.
   PubMed Web of Science ®Google Scholar
• Hughan KS, Tfayli H, Warren-Ulanch JG, et al. Early biomarkers of subclinical atherosclerosis in obese adolescent girls with polycystic ovary syndrome. J Pediatr. 2016;168:104–111. e1.
   PubMed Web of Science ®Google Scholar
• Ebejer K, Calleja-Agius J. The role of cytokines in polycystic ovarian syndrome. Gynecol Endocrinol. 2013;29(6):536–540.
   PubMed Web of Science ®Google Scholar
• Verit FF. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome. Arch Gynecol Obstet. 2010;281(6):1009–1014.
   PubMed Web of Science ®Google Scholar
• Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011;335(1):30–41.
   PubMed Web of Science ®Google Scholar
• Victor VM, Rovira-Llopis S, Bañuls C, et al. Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase. PLoS One. 2016;11(3):e0151960.
   PubMed Web of Science ®Google Scholar
• Rashad NM, El-Shal AS, Abomandour HG, et al. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome. J Ovarian Res. 2019;12(1):97.
   PubMed Web of Science ®Google Scholar
• Awad AM, Bradley MC, Fernández-Del-Río L, et al. Coenzyme Q10 deficiencies: pathways in yeast and humans. Essays Biochem. 2018;62(3):361–376.
   PubMed Web of Science ®Google Scholar
• Kapoor P, Kapoor A. Coenzyme Q10—a novel molecule. J Indian Acad Clin Med. 2013;14(1):37–45.
   Google Scholar
• Sharifi N, Tabrizi R, Moosazadeh M, et al. The effects of coenzyme Q10 supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des. 2018;24(23):2729–2742.
   PubMed Web of Science ®Google Scholar
• Huang H, Chi H, Liao D, et al. Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis. DMSO. 2018;11:875–886.
   Google Scholar
• Farsi F, Mohammadshahi M, Alavinejad P, et al. Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr. 2016;35(4):346–353.
   PubMed Web of Science ®Google Scholar
• Raygan F, Rezavandi Z, Tehrani SD, et al. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome. Eur J Nutr. 2016;55(8):2357–2364.
   PubMed Web of Science ®Google Scholar
• Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171(4):P1–P29.
   PubMed Web of Science ®Google Scholar
• Mirhashemi SM, Najafi V, Raygan F, et al. The effects of coenzyme Q10 supplementation on cardiometabolic markers in overweight type 2 diabetic patients with stable myocardial infarction: a randomized, double-blind, placebo-controlled trial. ARYA Atheroscler. 2016;12(4):158.
   PubMed Web of Science ®Google Scholar
• Izadi A, Ebrahimi S, Shirazi S, et al. Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;104(2):319–327.
   Web of Science ®Google Scholar
• Jamilian M, Foroozanfard F, Bahmani F, et al. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2016;170(2):271–278.
   PubMed Web of Science ®Google Scholar
• Samimi M, Zarezade Mehrizi M, Foroozanfard F, et al. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial. Clin Endocrinol. 2017;86(4):560–566.
   PubMed Web of Science ®Google Scholar
• Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395.
   PubMed Web of Science ®Google Scholar
• IPAQ Research Committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. 2005; [cited 2007 June 8]. Available from: http://www.ipaqkise/scoring.pdf.
   Google Scholar
• Sanoobar M, Eghtesadi S, Azimi A, et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci. 2015;18(4):169–176.
   PubMed Web of Science ®Google Scholar
• Bagheri Nesami N, Mozaffari-Khosravi H, Najarzadeh A, et al. The effect of coenzyme Q10 supplementation on pro-inflammatory factors and adiponectin in mildly hypertensive patients: a randomized, double-blind, placebo-controlled trial. Int J Vitam Nutr Res. 2015;85(3–4):156–164.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Huang YC, Chen SJ, et al. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition. 2012;28(7–8):767–772.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Tseng YF, Yen CH, et al. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013;12(1):142.
   PubMed Web of Science ®Google Scholar
• Pourmoghaddas M, Rabbani M, Shahabi J, et al. Combination of atorvastatin/coenzyme Q10 as adjunctive treatment in congestive heart failure: a double-blind randomized placebo-controlled clinical trial. ARYA Atheroscler. 2014;10(1):1–5.
   PubMedGoogle Scholar
• Gholami M, Rezvanfar MR, Delavar M, et al. Effects of coenzyme Q10 supplementation on serum values of gamma-glutamyl transferase, pseudocholinesterase, bilirubin, ferritin, and high-sensitivity c-reactive protein in women with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2019;127(05):311–319.
   PubMedGoogle Scholar
• Turhan H, Erbay AR, Yasar AS, et al. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia. Coron Artery Dis. 2005;16(1):45–50.
   PubMed Web of Science ®Google Scholar
• Mohseni M, Vafa M, Zarrati M, et al. Beneficial effects of coenzyme Q10 supplementation on lipid profile and intereukin-6 and intercellular adhesion molecule-1 reduction, preliminary results of a double-blind trial in acute myocardial infarction. Int J Prev Med. 2015;6(1):73.
   PubMedGoogle Scholar
• Soriano-Maldonado A, Hidalgo M, Arteaga P, et al. Effects of regular consumption of vitamin C-rich or polyphenol-rich apple juice on cardiometabolic markers in healthy adults: a randomized crossover trial. Eur J Nutr. 2014;53(8):1645–1657.
   PubMed Web of Science ®Google Scholar
• Hamdy NM, Suwailem SM, El-Mesallamy HO. Influence of vitamin E supplementation on endothelial complications in type 2 diabetes mellitus patients who underwent coronary artery bypass graft. J Diabetes Complications. 2009;23(3):167–173.
   PubMed Web of Science ®Google Scholar
• Rahmani E, Jamilian M, Samimi M, et al. The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(3):217–222.
   PubMed Web of Science ®Google Scholar
• Heidari A, Hamidi G, Soleimani A, et al. Effects of coenzyme Q10 supplementation on gene expressions related to insulin, lipid, and inflammation pathways in patients with diabetic nephropathy. Iran J Kidney Dis. 2018;12(1):14–21.
   PubMed Web of Science ®Google Scholar
• Schmelzer C, Lindner I, Rimbach G, et al. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors. 2008;32(1–4):179–183.
   PubMed Web of Science ®Google Scholar
• Mazidi M, Kengne AP, Banach M, Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2018;128:130–136.
   PubMed Web of Science ®Google Scholar
• Schmelzer C, Kubo H, Mori M, et al. Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator‐activated receptor‐α gene expression signature in SAMP1 mice. Mol Nutr Food Res. 2009;54(6):805–815.
   Web of Science ®Google Scholar
• Zhai J, Bo Y, Lu Y, et al. Effects of Coenzyme Q10 on markers of inflammation: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0170172.
   PubMed Web of Science ®Google Scholar
• Olivieri F, Lazzarini R, Babini L, et al. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation. Free Radic Biol Med. 2013;63:410–420.
   PubMed Web of Science ®Google Scholar
• Schmelzer C, Lorenz G, Rimbach G, et al. Influence of Coenzyme Q_{10} on release of pro-inflammatory chemokines in the human monocytic cell line THP-1. Biofactors. 2007;31(3–4):211–217.
   PubMed Web of Science ®Google Scholar